Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

12.33
Delayed Data
As of Dec 07
 -0.46 / -3.60%
Today’s Change
10.52
Today|||52-Week Range
19.98
-26.82%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close12.79
Today’s open12.65
Day’s range12.00 - 12.73
Volume1,408,244
Average volume (3 months)1,596,865
Market cap$2.0B
Dividend yield--
Data as of 12/07/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-80.60%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book269.15

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...-0.65-3.32%
ONCESpark Therapeutics I...-3.59-6.24%
FPRXFive Prime Therapeut...-6.02-10.13%
EXASExact Sciences Corp0.000.00%
Data as of 12/07/2016

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts


Search for Jobs